Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$4.08
NASDAQLPCN
Open
$3.88
Change
$0.16 (4.08%)
Day's Range
$3.87 - $4.39
52-Week Range
$2.31 - $11.79
Volume
26.6K
Market Cap
$21.8M
Currency in USD.
Quote data delayed by at least 15 minutes.